Search for: "In Re Opioid Litig."
Results 1 - 20
of 132
Sorted by Relevance
|
Sort by Date
8 Oct 2020, 7:03 pm
” The post Seeger Weiss urges a full-court review of proposed negotiation class in opioid litigation appeared first on Seeger Weiss LLP. [read post]
28 Jul 2020, 4:00 am
The Sixth Circuit will hear oral argument this morning (9:00 am EDT) in the Opioid MDL (In re: Nat’l Prescription Opiate Litigation, No. 19-4097 & 19-4099). [read post]
2 Aug 2022, 11:23 am
West Virginia has a long history of litigation with opioid distributors. [read post]
25 Sep 2020, 9:03 am
Yesterday, the Sixth Circuit issued a 2-1 decision in In re National Prescription Opiate Litigation, a much-anticipated case about the certification of a negotiation class in the Opioid MDL. [read post]
4 Feb 2019, 10:19 am
“We’re pleased ... [read post]
16 Sep 2019, 2:34 pm
RPLG Founding Partner Louise Renne has been appointed to serve as Co-Negotiation Class Counsel on multidistrict litigation for In Re: National Prescription Opiate Litigation. [read post]
27 Dec 2017, 8:08 am
In response to the opioid crisis, new litigation is beginning to percolate around the country against drug companies which make opioids, including right here in Philadelphia where the International Brotherhood of Electrical Workers 98 union has been talking about filing a lawsuit against the opioid makers. [read post]
4 Sep 2022, 1:34 am
The portal, which will be available in multiple languages, will be open for an initial 60-day comment period to inform planning and will re-open annually to facilitate ongoing input on the State’s opioid response and prevention efforts.Identifying information, such as the person’s name and email address, are optional. [read post]
21 Oct 2021, 9:50 am
Lead Counsel Jayne Conroy prepares for opening arguments in the ongoing consolidated opiate litigation in New York State at Touro College. [read post]
25 Feb 2020, 10:20 am
District Court for the Northern District of Ohio, styled In Re: National Prescription Opiate Litigation (MDL No. 2804) (the “MDL”). [read post]
31 Aug 2019, 8:25 am
Currently, an additional 2,000 opioid cases have been consolidated into the federal litigation that Hanly oversees. [read post]
7 Mar 2018, 8:09 am
Unlike the litigation it most resembles--tobacco--the opioid narrative has a far more complicated chain of causation. [read post]
13 Jan 2008, 6:23 pm
Patent Nos. 5,656,295; 5,508,042; and 5,549,912) for their OxyContin ® opioid pain relief formulations through inequitable conduct. [read post]
21 Jun 2018, 10:33 am
I know they may sound like names of background characters in a Lord of the Rings movie, but they’re all fentanyl-based medications, with more likely on the way. [read post]
3 Jul 2021, 11:29 am
While it's not shocking to see bare knuckle litigation harassment in a big bankruptcy, it is really troubling to see it going on in a case like Purdue. [read post]
16 Apr 2020, 6:14 am
Yesterday a Sixth Circuit panel issued its decision in In re National Prescription Opiate Litigation, granting the pharmacy defendants’ petition for a writ of mandamus regarding the district court’s order allowing the counties to amend their complaints to add new... [read post]
4 Mar 2024, 6:51 am
District Judge Dan Polster, who is overseeing the opioid multidistrict litigation in the Northern District of Ohio, raised several questions to Motley Rice’s Linda Singer about her responsibilities as outside counsel in government lawsuits against the same defendants her firm has sued in the opioid cases—specifically, pharmacy benefit manager OptumRx Inc., owned by United HealthCare. [read post]
30 Nov 2017, 8:59 pm
III) MDL No. 2802 – In re: Epipen (Epinephrine Injection, USP) Employee Retirement Income Security Act (ERISA) Litigation MDL No. 2804 – In re: National Prescription Opiate Litigation MDL No. 2806 – In re: McGregor-Mayweather Boxing Match Pay-Per-View Litigation MDL No. 2807 – In re: Sonic Corp. [read post]
4 Feb 2023, 5:26 pm
In re Caremark Int’l Inc. [read post]
15 Oct 2020, 6:32 am
Yesterday, Judge Polster partially granted the plaintiffs’ motion for sanctions against the Allergan and Teva defendants in the In re: National Prescription Opiate Litigation MDL. [read post]
